These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1392173
1. Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction. Uyama O, Shimizu S, Nakanishi T, Nakahama H, Takiguchi A, Hayashi Y, Yamamoto S, Sugita M. Intern Med; 1992 Jun; 31(6):735-9. PubMed ID: 1392173 [Abstract] [Full Text] [Related]
2. Risk factors for carotid atherosclerosis and platelet activation. Uyama O, Matsui Y, Shimizu S, Michishita H, Sugita M. Jpn Circ J; 1994 Jun; 58(6):409-15. PubMed ID: 8065012 [Abstract] [Full Text] [Related]
8. Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. Rebuzzi AG, Natale A, Bianchi C, Albanese S, Lanza GA, Coppola E, Ciabattoni G. Am Heart J; 1992 Mar 15; 123(3):560-6. PubMed ID: 1539506 [Abstract] [Full Text] [Related]
9. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. Patrignani P, Morton H, Cirino M, Lord A, Charette L, Gillard J, Rokach J, Patrono C. Biochim Biophys Acta; 1989 Jul 21; 992(1):71-7. PubMed ID: 2752041 [Abstract] [Full Text] [Related]
14. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Davì G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C. Circulation; 1997 Jul 01; 96(1):69-75. PubMed ID: 9236419 [Abstract] [Full Text] [Related]